Journal Mobile Options
Table of Contents
Vol. 132, No. 2, 2003
Issue release date: October 2003
Int Arch Allergy Immunol 2003;132:132–140

How Accurate and Safe Is the Diagnosis of Hazelnut Allergy by Means of Commercial Skin Prick Test Reagents?

Akkerdaas J.H. · Wensing M. · Knulst A.C. · Krebitz M. · Breiteneder H. · de Vries S. · Penninks A.H. · Aalberse R.C. · Hefle S.L. · van Ree R.
aDepartment of Immunopathology, Sanquin Research at CLB, Amsterdam, bDepartment of Dermatology and Allergology, UMCU, Utrecht, cDepartment of Plant Sciences, Wageningen University, Wageningen, and dTNO Nutrition and Food Research, Zeist, The Netherlands; eDepartment of Pathophysiology, University of Vienna, Vienna, Austria; fFood Allergy Research and Resource Program, University of Nebraska, Lincoln, Nebr., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Allergy to tree nuts, like hazelnuts, ranks among the most frequently observed food allergies. These allergies can start at early childhood and are, in contrast to other food allergies, not always outgrown by the patient. Tree nut allergy is frequently associated with severe reactions. Diagnosis partially relies on in vivo testing by means of a skin prick test (SPT) using commercially available SPT reagents. Methods: Protein and allergen composition of nine commercial SPT solutions was evaluated using standard protein detection methods and specific immunoassays for measurement of five individual allergens. Diagnostic performance was assessed by SPT in 30 hazelnut-allergic subjects, of which 15 were provocation proven. Results: Protein concentrations ranged from 0.2–14 mg/ml. SDS-PAGE/silver staining revealed clear differences in protein composition. The major allergen Cor a 1 was present in all extracts but concentrations differed up to a factor 50. An allergen associated with severe symptoms, Cor a 8 (lipid transfer protein), was not detected on immunoblot in three products, and concentrations varied by more than a factor 100 as was shown by RAST inhibition. Similar observations were made for profilin, thaumatin-like protein and a not fully characterized 38-kD allergen. Ratios of individual allergens were variable among the nine extracts. SPT showed significant difference, and 6/30 patients displayed false-negative results using 3/9 products. Conclusion: Variability in the composition of products for the diagnosis of hazelnut allergy is extreme. Sometimes, allergens implicated in severe anaphylaxis are not detected by immunoblotting. These shortcomings in standardisation and quality control can potentially cause a false-negative diagnosis in subjects at risk of severe reactions to hazelnuts.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Tariq SM, Stevens M, Matthews S, Ridout S, Twiselton R, Hide DW: Cohort study of peanut and tree nut sensitisation by age of 4 years. BMJ 1996;313:514–517.
  2. Emmett SE, Angus FJ, Fry JS, Lee PN: Perceived prevalence of peanut allergy in Great Britain and its association with other atopic conditions and with peanut allergy in other household members. Allergy 1999;54:380–385.
  3. Sicherer SH, Munoz-Furlong A, Burks AW, Sampson HA: Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. J Allergy Clin Immunol 1999;103:559–562.
  4. Pumphrey RS, Stanworth SJ: The clinical spectrum of anaphylaxis in north-west England. Clin Exp Allergy 1996;26:1364–1370.
  5. Ortolani C, Ballmer-Weber BK, Hansen KS, Ispano M, Wuthrich B, Bindslev-Jensen C, et al: Hazelnut allergy: A double-blind, placebo-controlled food challenge multicenter study. J Allergy Clin Immunol 2000;105:577–581.
  6. Bock SA, Munoz-Furlong A, Sampson HA: Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191–193.
  7. Hirschwehr R, Valenta R, Ebner C, Ferreira F, Sperr WR, Valent P, et al: Identification of common allergenic structures in hazel pollen and hazelnuts: A possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen. J Allergy Clin Immunol 1992;90:927–936.
  8. Asero R: Detection and clinical characterization of patients with oral allergy syndrome caused by stable allergens in Rosaceae and nuts. Ann Allergy Asthma Immunol 1999;83:377–383.
  9. Pastorello EA, Farioli L, Pravettoni V, Ortolani C, Ispano M, Monza M, et al: The major allergen of peach (Prunus persica) is a lipid transfer protein. J Allergy Clin Immunol 1999;103:520–526.
  10. Sanchez-Monge R, Lombardero M, Garcia-Selles FJ, Barber D, Salcedo G: Lipid-transfer proteins are relevant allergens in fruit allergy. J Allergy Clin Immunol 1999;103:514–519.
  11. Asero R, Mistrello G, Roncarolo D, de Vries SC, Gautier MF, Ciurana CL, et al: Lipid transfer protein: A pan-allergen in plant-derived foods that is highly resistant to pepsin digestion. Int Arch Allergy Immunol 2001;124:67–69.
  12. Pastorello EA, Farioli L, Pravettoni V, Ispano M, Conti A, Ansaloni R, et al: Sensitization to the major allergen of Brazil nut is correlated with the clinical expression of allergy. J Allergy Clin Immunol 1998;102:1021–1027.
  13. Kelly JD, Hlywka JJ, Hefle SL: Identification of sunflower seed IgE-binding proteins. Int Arch Allergy Immunol 2000;121:19–24.
  14. McPherson A, Weickmann J: X-ray analysis of new crystal forms of the sweet protein thaumatin. J Biomol Struct Dyn 1990;7:1053–1060.
  15. Krebitz M, Peterbauer C, Ferreira F, Essl D, Steinkellner H, Scheiner O, et al: Production of Mal d 2, a major allergen from apple (Malus domestica), in a plant based expression system, and its biological activity against pathogens (abstract). J Allergy Clin Immunol 2001;2:188.
  16. Sampson HA, Ho DG: Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997;100:444–451.
  17. Dreborg S, Foucard T: Allergy to apple, carrot and potato in children with birch pollen allergy. Allergy 1983;38:167–172.
  18. Wensing M, Penninks AH, Hefle SL, Akkerdaas J, van Ree R, Koppelman S, et al: The range of minimum provoking doses in hazelnut-allergic patients as determined by double-blind placebo-controlled food challenges (DBPCFCs). Clin Exp Allergy 2002;32:1757–1762.
  19. Bjorksten F, Halmepuro L, Hannuksela M, Lahti A: Extraction and properties of apple allergens. Allergy 1980;35:671–677.
  20. Akkerdaas JH, van Ree R, Aalbers M, Stapel SO, Aalberse RC: Multiplicity of cross-reactive epitopes on Bet v I as detected with monoclonal antibodies and human IgE. Allergy 1995;50:215–220.
  21. van Ree R, Voitenko V, van Leeuwen A, Aalberse RC: Profilin is a cross-reactive allergen in pollen and vegetable foods. Int Arch Allergy Immunol 1992;98:97–104.
  22. Sterk P, Booij H, Schellekens GA, Van Kammen A, de Vries SC: Cell-specific expression of the carrot EP2 lipid transfer protein gene. Plant Cell 1991;3:907–921.
  23. Hoffmann-Sommergruber K, Witty M, Campillo N, Krebitz M, Fuchs H, Ebner C, et al: Pru p 2, Mal d 2 and Cap a 1 are thaumatin allergens (abstract). Abstract Book 2001.
  24. van Ree R, Van Leeuwen WA, van den Berg M, Weller HH, Aalberse RC: IgE and IgG cross-reactivity among Lol p I and Lol p II/III. Identification of the C-termini of Lol p I, II, and III as cross-reactive structures. Allergy 1994;49:254–261.
  25. Aalberse RC, Koshte V, Clemens JG: Immunoglobulin E antibodies that cross-react with vegetable foods, pollen and Hymenoptera venom. J Allergy Clin Immunol 1983;68:356.
  26. Dreborg S, Frew A: Allergen standardisation and skin tests. Allergy 1993;48(suppl 114):49–82.
  27. Pastorello EA, Vieths S, Pravettoni V, Farioli L, Trambaioli C, Fortunato D, et al: Identification of hazelnut major allergens in sensitive patients with positive double-blind, placebo-controlled food challenge results. J Allergy Clin Immunol 2002;109:563–570.
  28. Scheurer S, Pastorello EA, Wangorsch A, Kastner M, Haustein D, Vieths S: Recombinant allergens Pru av 1 and Pru av 4 and a newly identified lipid transfer protein in the in vitro diagnosis of cherry allergy. J Allergy Clin Immunol 2001;107:724–731.
  29. Nordlee JA, Taylor SL, Townsend JA, Thomas LA, Bush RK: Identification of a Brazil-nut allergen in transgenic soybeans. N Engl J Med 1996;334:688–692.
  30. Luttkopf D, Muller U, Skov PS, Ballmer-Weber BK, Wuthrich B, Skamstrup HK, et al: Comparison of four variants of a major allergen in hazelnut (Corylus avellana) Cor a 1.04 with the major hazel pollen allergen Cor a 1.01. Mol Immunol 2002;38:515–525.
  31. Schocker F, Luttkopf D, Scheurer S, Petersen A, Vieths S, Becker WM: Cloning and sequencing of the lipid transfer protein from hazelnut (Corylus avellana) (abstract). EAACI Abstract Book 2001, p 66.
  32. Wensing M, Akkerdaas JH, Van Leeuwen WA, Stapel SO, Bruijnzeel-Koomen CA, Aalberse RC, et al: IgE to Bet v 1 and profilin: Cross-reactivity patterns and clinical relevance. J Allergy Clin Immunol 2002;110:435–442.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50